Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF PEDIATRICS   MARCH 2010 , Volume 20 , Number 1; Page(s) 48 To 52.
 
Paper: 

THE EFFECT OF CLOFIBRATE ON DECREASING SERUM BILIRUBIN IN HEALTHY TERM NEONATES UNDER HOME PHOTOTHERAPY

 
 
Author(s):  SHARAFI R.*, MORTAZAVI ZH., SHARAFI S., MORADI PARASHKOUH R.
 
* DEPARTMENT OF PEDIATRICS, GUILAN UNIVERSITY OF MEDICAL SCIENCES, RASHT, IRAN
 
Abstract: 
Objective: this study was designed to determine the effect of clofibrate on neonatal uncomplicated jaundice treated with home phototherapy.
Methods: This clinical trial study was performed on 60 newborns with jaundice that received home phototherapy. Inclusion criteria were body weight between 2500 to 4000 gr, breastfed, total serum bilirubin (TSB) between 14 to 20 mg/dl, aged over 72 hours. The neonates were randomly divided into two groups. All received home phototherapy. Group i received a single dose of 50 mg/kg clofibrate and the other group served as control group. Total serum bilirubin level was measured every 24 hours.
Findings: Two groups were matched regarding weight, sex, age and first TSB. At 24 and 48 hours of treatment, the mean values of TSB in the clofibrate group were 13.72 (1.56), 9.5 (0.56) and in the control group 15.30 (1.44), 12.6 (1.44). The results show that TSB was significantly decreased after 24 and 48 hours in clofibrate group (P<0.001). The mean duration of phototherapy in group I was 72(0.0) hours and in the control group 76.80 (
±9.76) hours. The duration of phototherapy was significantly shorter in clofibrate group (P<0.001).
Conclusion: Clofibrate is effective for outpatients with neonatal hyperbilirubinemia who are under home phototherapy. Of course, further studies are needed for approved routine use of this drug in the treatment of neonatal jaundice.
 
Keyword(s): CLOFIBRATE, PHOTOTHERAPY, HOME CARE, NEONATAL HYPERBILIRUBINEMIA, JAUNDICE
 
References: 
  • ندارد
 
  Yearly Visit 76
 
Latest on Blog
Enter SID Blog